The Incredible Career and Life of Scott Rocklage

Attending college and being awarded a degree is a common thing. However, applying one’s education in real life to stand out from others is a great achievement.

Against all odds, Dr. Scott Rocklage studied hard to receive his B.S in chemistry, and he never gave up until he completed his Ph.D. studies in the same. The two academic qualifications were received from the University of California and the Massachusetts Institute of Technology respectively.  Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift and http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY

Although most people study chemistry to be awarded a degree so as to secure better jobs, this course was a passion for Dr. Scott Rocklage. This can be depicted by relentless efforts and hard work that made him receive the Nobel Prize in Chemistry back in 2005.

Today, he is acknowledged for being an inventor or a co-inventor on more than 30 U.S. patents. Besides, peer-reviewed publications that relate to him are not less than 100. Presently, people willing to meet him can book appointments in Boston, MA office.

Scott M. Rocklage, Ph.D. has provided his services in a number of companies. Most notably, in 2003, he became of the staff members of 5AM Ventures as a distinguished Venture Partner. Based on his qualifications and input, he surprisingly climbed the ladder to becoming a Managing partner in 2004, after only a year of experience with this company.

That said, it is important to note that Scott Rocklage has over 30 years of experience in the field of healthcare management. Some of his notable achievements include the successful approval of 3 different U.S. New Drug Applications by the FDA.

Other than 5AM Ventures, Dr. Rocklage has served as the chairman as well as the CEO of Cubist Pharmaceuticals. Additionally, he held the same senior positions in Nycomed Salutor, and he has also been a manager at Salutar and Catalytica.

At the moment, Dr. Scott Rocklage serves as a Board Chairman of various companies including Kinestral, Rennovia, and Cidara. He was able to secure these positions due to his past positions in Ilypsa which was acquired by Amgen, and Miikana which was as well acquired by EntreMed.